Get Healthy!

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

June 23, 2025
HealthDayTV HealthDay Reporter

In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.

Headaches Migraine

Health News is provided as a service to Pharmcare Pharmacy LTC site users by HealthDay. Pharmcare Pharmacy LTC nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Patient Resources

Get Healthy!

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

Health News is provided as a service to Pharmcare Pharmacy LTC site users by HealthDay. Pharmcare Pharmacy LTC nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags